C12Y 304/21069
Protein c activated
Official title: Protein C activated (3.4.21.69)
C12Y304/21069 (Protein c activated) appears on 445 US grants and 180 published applications in this corpus.
Search patents in C12Y- Granted patents
- 445
- Published applications
- 180
- Assignees
- 183
- Inventors
- 688
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 25 | 0 |
| 1991 | 24 | 0 |
| 1992 | 32 | 0 |
| 1993 | 31 | 0 |
| 1994 | 19 | 0 |
| 1995 | 20 | 0 |
| 1996 | 24 | 0 |
| 1997 | 33 | 0 |
| 1998 | 38 | 0 |
| 1999 | 25 | 0 |
| 2000 | 19 | 0 |
| 2001 | 13 | 4 |
| 2002 | 16 | 10 |
| 2003 | 12 | 18 |
| 2004 | 9 | 19 |
| 2005 | 8 | 12 |
| 2006 | 7 | 11 |
| 2007 | 7 | 5 |
| 2008 | 3 | 5 |
| 2009 | 4 | 8 |
| 2010 | 4 | 7 |
| 2011 | 3 | 7 |
| 2012 | 6 | 9 |
| 2013 | 3 | 10 |
| 2014 | 10 | 6 |
| 2015 | 4 | 7 |
| 2016 | 2 | 0 |
| 2017 | 3 | 8 |
| 2018 | 3 | 5 |
| 2019 | 3 | 5 |
| 2020 | 2 | 5 |
| 2021 | 4 | 2 |
| 2022 | 4 | 3 |
| 2023 | 2 | 4 |
| 2024 | 1 | 2 |
| 2025 | 1 | 6 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Protein C zymogen and methods of use thereof to prevent cancer metastases20 Jan 2026US 12,527,848 B2The Children’s Hospital of Philadelphia
- Use of APC analogue for wound healing4 Feb 2025US 12,214,024 B2ZZ Biotech LLC
- Recombinant Factor C and method for producing the same, and method for measuring endotoxin16 Apr 2024US 11,959,109 B2Seikagaku Corporation
- Mirac proteins8 Aug 2023US 11,718,844 B2BioAtla, Inc.
- Treatment of inflammatory skin disorders4 Apr 2023US 11,617,785 B2ZZ Biotech LLC
- Method for producing recombinant horseshoe crab factor, endotoxin assay agent, and method for producing endotoxin assay agent23 Jul 2026US 2026/0209738 A1Seikagaku Corporation
- Processing and fabrication of composite silk-based plastics8 Jan 2026US 2026/0009013 A1
- Sequence of activated protein c5 Jun 2025US 2025/0177571 A1Jichi Medical University
- Novel recombinant factor c and method for producing the same, and method for measuring endotoxin29 May 2025US 2025/0171759 A1Seikagaku Corporation
- Novel recombinant factor c and method for producing the same, and method for measuring endotoxin29 May 2025US 2025/0171760 A1Seikagaku Corporation
Most cited
By later US patents
- Method for dominant selection in eucaryotic cells277US 5,122,464 ACelltech Limited, a British Company · 1992
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998
- Vectors and methods for transformation of eucaryotic cells219US 4,740,461 AGenetics Institute, Inc. · 1988
- Method for making variant secreted proteins with altered properties199US 5,223,408 AGenentech, Inc. · 1993
- Method for culturing Chinese hamster ovary cells186US 5,633,162 AGlaxo Wellcome Inc. · 1997